Education
- BS, Chemistry: BRABU (Muzaffarpur, India) (2002)
- MS, Biochemistry: Jamia Hamdard (New Delhi, India) (2005)
- PhD, Biophysics, Cancer Biology: All India Institute of Medical Sciences (New Delhi, India) (2012)
Biography
Dr. Abhay Singh joined the faculty at Washington University in 2021 after completing his postdoctoral research in Dr. Dennis Hallahan’s lab at the Department of Radiation Oncology at Washington University. Dr. Singh earned his PhD from the All India Institute of Medical Sciences, New Delhi. He has extensive training in molecular biology, cancer biology and protein and peptide chemistry. His research involves antibody engineering, drug development, the discovery of novel therapeutic targets, and treatment strategies for cancer. Dr. Singh discovered novel cancer targeting human scFvs using phage-displayed human scFv library. He grafted the variable region of scFvs into different formats of therapeutic antibody. Dr. Singh’s goal is to characterize the lead antibody, which can be translated to the clinic.